XML 60 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2023
Segment Reporting Information [Line Items]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
As of and for the Three Months Ended September 30,
(In millions)
SeedCrop ProtectionTotal
2023   
Net sales$878 $1,712 $2,590 
Segment operating EBITDA$(138)$184 $46 
Segment assets1
$22,829 $15,446 $38,275 
2022   
Net sales$862 $1,915 $2,777 
Segment operating EBITDA$(224)$352 $128 
Segment assets1
$22,665 $13,474 $36,139 
1.    Segment assets at December 31, 2022 were $22,952 million and $14,097 million for Seed and Crop Protection, respectively.
For the Nine Months Ended September 30,
(In millions)
SeedCrop ProtectionTotal
2023   
Net sales$7,837 $5,682 $13,519 
Segment operating EBITDA$1,972 $1,107 $3,079 
2022 
Net sales$7,333 $6,297 $13,630 
Segment operating EBITDA$1,585 $1,352 $2,937 
Reconciliation of Assets from Segment to Consolidated [Table Text Block]
Segment assets to total assets (in millions)
September 30, 2023December 31, 2022September 30, 2022
Total segment assets$38,275 $37,049 $36,139 
Corporate assets4,835 5,569 4,512 
Total assets$43,110 $42,618 $40,651 
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Reconciliation to interim Consolidated Financial Statements
Income (loss) from continuing operations after income taxes to segment operating EBITDA

(In millions)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Income (loss) from continuing operations after income taxes$(315)$(322)$1,172 $1,257 
Provision for (benefit from) income taxes on continuing operations(129)(74)244 372 
Income (loss) from continuing operations before income taxes(444)(396)1,416 1,629 
Depreciation and amortization306 310 899 919 
Interest income(59)(36)(153)(75)
Interest expense58 18 171 43 
Exchange (gains) losses102 13 242 96 
Non-operating (benefits) costs28 (9)115 (134)
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges(44)(6)34 (3)
Significant items (benefit) charge71 202 271 379 
Corporate expenses28 32 84 83 
Segment operating EBITDA$46 $128 $3,079 $2,937 
Segment, Reconciliation of Other Items from Segments to Consolidated
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended September 30, 2023
Restructuring and asset related charges - net1
$$— $(3)$(2)
Estimated settlement expense2
— (66)— (66)
Gain (loss) on sale of business, assets and equity investments3
— — 
Acquisition-related costs5
— (7)— (7)
Total$$(73)$(3)$(71)
(In millions)SeedCrop ProtectionCorporateTotal
For the Three Months Ended September 30, 2022
Restructuring and asset related charges - net1
$(66)$(20)$(66)$(152)
Estimated settlement expense2
— (40)— (40)
Inventory write-offs3
(32)— — (32)
Gain (loss) on sale of business, assets and equity investments3
— 15 — 15 
Settlement costs associated with Russia Exit3
(2)— — (2)
Employee Retention Credit— 
Total$(94)$(42)$(66)$(202)

(in millions)SeedCrop ProtectionCorporateTotal
For the Nine Months Ended September 30, 2023
Restructuring and asset related charges - net1
$(74)$(11)$(10)$(95)
Estimated settlement expense2
— (156)— (156)
Inventory write-offs3
(7)— — (7)
Gain (loss) on sale of business, assets and equity investments3
— 
Seed sale associated with Russia Exit3,4
18 — — 18 
Acquisition-related costs5
— (41)— (41)
Employee Retention Credit— — 
Total$(59)$(202)$(10)$(271)

(in millions)SeedCrop ProtectionCorporateTotal
For the Nine Months Ended September 30, 2022
Restructuring and asset related charges - net1
$(197)$(20)$(83)$(300)
Estimated settlement expense2
— (57)— (57)
Inventory write-offs3
(33)— — (33)
Gain (loss) on sale of business3
— 15 — 15 
Loss on sale of equity investment3
(5)— — (5)
Settlement costs associated with Russia Exit3
(8)— — (8)
Employee Retention Credit— 
Total$(237)$(59)$(83)$(379)
1.Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 5 - Restructuring and Asset Related Charges - Net, to the interim Consolidated Financial Statements, for additional information.
2.Consists of estimated Lorsban® related charges.
3.Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions.
4.Includes a benefit (charge) of $18 million for the nine months ended September 30, 2023, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the company was contractually required to purchase. It consists of $71 million of net sales and $53 million of cost of goods sold for the nine months ended September 30, 2023.
5.Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 3 - Business Combinations, to the interim Consolidated Financial Statements, for additional information.